Carla Lusby

VP Of Finance Transformation at Lifecore Biomedical

Carla Lusby is an experienced finance professional with a strong background in financial management and transformation. Currently serving as VP of Finance Transformation at Lifecore Biomedical since December 2024, Carla previously held the position of VP of Finance at Societal™ CDMO from November 2020 to December 2024. Prior to that, Carla was Director of Finance at Recro Pharma, Inc. from July 2017 to November 2020 and has also worked at DSM in various roles including Business Unit Controller and Senior Project Manager from April 2013 to June 2017. Carla began their career at Kensey Nash Corporation, where significant roles included Sr Financial Planning & Analysis Manager. Academically, Carla holds an MBA from Saint Joseph's University and a degree from Cairn University.

Location

Philadelphia, United States

Links


Org chart

No direct reports

Teams

This person is not in any teams


Offices

This person is not in any offices


Lifecore Biomedical

Lifecore Biomedical is a full-service contract development and manufacturing organization (CDMO) that partners with pharmaceutical and biotech companies to develop and deliver vital and complex injectable therapies. From formulation to commercialization, we have everything it takes to move your project to the next level, making progress possible for our partners, people and most importantly, patients. Working from two dedicated, state-of-the-art facilities, our people are subject matter experts, our capabilities customized, our processes and systems qualified and our infrastructure optimized to meet your most sophisticated requirements regardless of scale. Our expertise is in drug products that are challenging and difficult to formulate, sterile filter, and aseptically fill. We've been the global leader in pharmaceutical-grade sodium hyaluronate (NaHy) for nearly 40 years. Leveraging this experience alongside deep expertise and capabilities in highly viscous solutions, we create tailored solutions that solve your drug development challenges across the entire development and manufacturing lifecycle. Our capabilities: Sterile Injectable Development - Formulation Development - Sterilization Development - Process Development - Analytical Services & Stability - Engineering Services - Validation Services Sterile Injectable Manufacturing - Sterilization - Aseptic Filling - Packaging - Analytical Services & Stability


Employees

201-500

Links